CAS 944118-01-8: Peficitinib
Fórmula:C18H22N4O2
InChI:InChI=1/C18H22N4O2/c19-16(23)13-8-21-17-12(1-2-20-17)15(13)22-14-10-3-9-4-11(14)7-18(24,5-9)6-10/h1-2,8-11,14,24H,3-7H2,(H2,19,23)(H2,20,21,22)
Clave InChI:InChIKey=DREIJXJRTLTGJC-UHFFFAOYNA-N
SMILES:O=C(N)C1=CN=C2NC=CC2=C1NC3C4CC5CC3CC(O)(C5)C4
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Peficitinib REF: IN-DA00II55CAS: 944118-01-8 | 98% | A consultar | Lun 03 Mar 25 |
 | Peficitinib REF: TM-T6933CAS: 944118-01-8 | 98.67% - 99.4% | A consultar | Lun 10 Mar 25 |
 | Peficitinib REF: 3D-UMB11801CAS: 944118-01-8 | Min. 95% | - - - | Producto descatalogado |
Ref: IN-DA00II55
| 100mg | 172,00 € | ||
| 250mg | 231,00 € |
Entrega estimada en Estados Unidos, el Lunes 3 de Marzo de 2025
Peficitinib
CAS:944118-01-8
Peficitinib (ASP015K) (ASP015K, JNJ-54781532) is an orally bioavailable JAK inhibitor. Phase 3.
Fórmula:
C18H22N4O2
Pureza:
98.67% - 99.4%
Forma y color:
Solid
Peso molecular:
326.39
Ref: TM-T6933
| 2mg | 40,00 € | ||
| 5mg | 66,00 € | ||
| 10mg | 104,00 € | ||
| 25mg | 182,00 € | ||
| 50mg | 283,00 € | ||
| 100mg | 439,00 € | ||
| 200mg | 645,00 € | ||
| 1mL*10mM (DMSO) | 73,00 € |
Entrega estimada en Estados Unidos, el Lunes 10 de Marzo de 2025
Peficitinib
CAS:944118-01-8
Peficitinib is a selective inhibitor of the Janus kinase (JAK) family. It has been shown …
Fórmula:
C18H22N4O2
Pureza:
Min. 95%
Peso molecular:
326.39 g/mol
Ref: 3D-UMB11801
| 1mg | Descatalogado | Solicitar información | |
| 2mg | Descatalogado | Solicitar información | |
| 5mg | Descatalogado | Solicitar información | |
| 10mg | Descatalogado | Solicitar información | |
| 25mg | Descatalogado | Solicitar información | |
| 50mg | Descatalogado | Solicitar información | |
| 100mg | Descatalogado | Solicitar información |
